AMPEL BioSolutions’ Machine Learning Breakthrough Predicts Chronic Disease Flares from a Blood Sample

Recent Posts

• Virginia Workforce Award to AMPEL BioSolutions
• Charlottesville-area company receives praise for internship program
• Innovator-of-Year to AMPEL
• Innovators, Educators, and Entrepreneurs Recognized at North Fork
• From Genomic Tests to AI Predictions: Dr. Amrie Grammer, Co-Founder of AMPEL BioSolutions, Joins BioTalk
• Virginia Catalyst Awards $2 Million in Grants to Support Life Sciences in the Commonwealth
• Virginia Catalyst Announces AMPEL as Grant Round 14 Awardee
• AMPEL BioSolutions Developing Molecular Test to Predict Kidney Damage in Lupus Nephritis Patients